Abstract:A 6-azido-β-cyclodextrin was synthesized and derivatized with p-nitrophenyl isocyanate as chiral ligand. Then the ligand was chemically bonded to mesoporous SBA-15 via a ‘Click Chemistry’ reaction of the azido group with alkynyl group. A new p-nitrophenylcarbamoylated β-cyclodextrin bonded SBA-15 chiral stationary phase (NPCSP) for HPLC was thus obtained. The new stationary phase was first used for enantioseparation of propranolol in human plasma under the polar organic solvent mode. The effects of methanol content, concentration of glacial acetic acid/triethylamine in mobile phase and the temperature on the enantioseparation were studied in detail. The optimized chromatographic conditions were as follows: mobile phase was acetonitrile/methanol/glacial acetic acid/triethylamine (90/10/1.25/2.25, V/V) at 288 K, with a flow rate of 0.5 mL min−1, an injection volume of 20 μL and detection wavelength at 290 nm. The resolution was 2.04 with a short run time (< 15 min) under the optimal conditions. The content of propranolol in plasma was quantitatively measured by HPLC-MS under selected ion monitoring mode ([M + H]+ m/z 260.10) with hydrochlorothiazide as an internal standard. The good linear relationship was observed in the range of 2.5−50 μg L−1. The detection limits were 1 μg L−1 according to S/N = 3 for both enantiomers. The experimental results showed that the chiral stationary phase exhibited excellent chiral separation ability to propranolol. The analytical method for propranolol enantiomers was sensitive, accurate, simple and fast, which was can be for the determination of propranolol in plasma and related pharmacokinetic studies.

Resolution of propranolol hydrochloride using chiral selector impregnated thin-layer chromatography

Chiral separation of propranolol hydrochloride by smb process integrated with crystallization

Chiral separation of propranolol hydrochloride through an SNM process integrated with crystallization

Separation of fluoxetine hydrochloride enantiomers on cyclodextrin chiral stationary phase

Highly Resolution Of Propranolol Using Oxidized Multi-Walled Carbon Nanotubes And Beta-Cyclodextrin Derivatives As Impregnating Reagents

Simultaneous Resolution of Clenbuterol Hydrochloride Enantiomers and Propranolol Hydrochloride Enantiomers Using Thin-Layer Chromatography

Resolution of Clenbuterol Hydrochloride Enantiomers Using Hydroxypropyl-Β-cyclodextrin-impregnated Thinlayer Chromatography

Synthesis of Hydroxypropyl-β-cyclodextrin Bonded Silica-gel and Its Application to Resolution

Separation Of Terfenadine Enantiomers By High Performance Liquid Chromatography Using Beta-Cyclodextrin As Chiral Mobile Phase Additive

2-O-(2-hydroxybutyl)-β-cyclodextrin As a Chiral Selector for the Capillary Electrophoretic Separation of Chiral Drugs

Resolution of Chlorthalidone Enantiomers by High Performance Liquid Chromatography with Chiral Mobile Phase Additive

Chiral Resolution of Fluoxetine and Carteolol by High Performance Capillary Electrophoresis

Enantioseparation and Determination of Propranolol in Human Plasma on a New Derivatized Β-Cyclodextrin Bonded Phase by HPLC

6-O-(2-hydroxybutyl)-β-cd As a Chiral Selector for Nonaqueous Capillary Electrophoretic Separation of Chiral Drugs

Evaluation of chiral dehydroabietic acid-terminated tetra-arm PEG as an assisted phase-forming polymer and chiral selector for the enantioseparation of propranolol racemate in aqueous two-phase systems

Chiral Separation of Propranolol Enantiomers by Oxidized Multiwalled Carbon Nanotubes/β-cyclodextrin Impregnated Thin-layer Chromatography

Enantioseparation of Benazepril Intermediates by High‐Performance Liquid Chromatography on Chiral CDMPC Column

Enantioselective Separation of Propranolol Enantiomers by Chiral Extraction

Resolution of Chiral Drug Enantiomers of Alkaloids by High Performance Liquid Chromatography

Chiral Resolution of Basic Pharmaceutical Enantiomers by Capillary Zone Electrophoresis

Chiral Resolution of Fluoxetine and Cetirizine by Dynamically Dual - coating Capillary Electrochromatography